Polypill/Aspirin Combination Reduces Cardiovascular Events in Participants with Increased CV Risk
How to Cite
OrthoEvidence. Polypill/Aspirin Combination Reduces Cardiovascular Events in Participants with Increased CV Risk. ACE Report. 2020;9(11):34. Available from: https://myorthoevidene.com/AceReport/Report/12645
Polypill with or without Aspirin in Persons without Cardiovascular DiseaseN Engl J Med. 2020 Nov 13.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Five thousand, seven hundred and thirteen patients with elevated cardiovascular risk were randomized to receive a polypill (containing lipid and blood pressuring lowering agents), aspirin, polypill and aspirin, or placebo for the prevention of cardiovascular events. The primary outcome of interest for the polypill and polypill plus aspirin groups was a composite of death from major cardiovascular ...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE